Direkt zum Inhalt
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
DE
FR
EN
PT
NL
NB
DE
IT
Startseite
Company Press Releases
Company press releases
Abonnieren
Filter
Filter
Aktualisieren
Zurücksetzen
Icon After
Datum
Toggle Visibility
Alle
Heute
This week
This month
Custom date range
From
To
Topic
Toggle Visibility
Acquisition or disposal of the issuer’s own shares
Additional regulated information required to be disclosed under the laws of a Member State
Adjustment of interest rate
Alliances and agreements
Annual financial and audit Reports
Change in Capital
Changes in the rights attaching to the classes of shares or securities
Commercial operations
Commercial results
Corporate life
Dividend
Ex Date
General meeting / Board Meeting
Half yearly financial reports and audit reports/limited reviews
Home Member State
Income
Inside information
Joint venture
Journal / appointments
Legal
Major shareholding notifications
Mandatory notification of trade primary insiders
Meetings / events
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Non-regulatory press releases
Other financial transaction
Other subject
Payments to governments
Polls / Surveys
Products and services
Prospectus / admission document
Rating
Sales
Share history
Share introduction and issues
Takeover bids
Total number of voting rights and capital
Trends / Analyses
Provider
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Displaying 201 - 229 of 229 results
Released
Company
Title
Industry
Topic
12 Oct 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics se dote d’un Conseil Scientifique pour le développement de sa plateforme de thérapies cellulaires et géniques basées sur des Cellules Souches Mésenchymateuses induites (CSMi)
20103010 Biotechnology
Corporate life
28 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
20103010 Biotechnology
Alliances and agreements
28 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics signe un partenariat de recherche avec Implant Therapeutics pour garantir son accès à des Cellules Souches Pluripotentes induites (CSPi)
20103010 Biotechnology
Alliances and agreements
21 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer
20103010 Biotechnology
Corporate life
21 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics nomme Lieve Creten en qualité de Directeur financier par intérim
20103010 Biotechnology
Corporate life
08 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics publie ses résultats du premier semestre 2021
20103010 Biotechnology
Other subject
08 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics reports half year 2021 results
20103010 Biotechnology
Other subject
07 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA réagit au communiqué de presse publié par Hybrigenics
20103010 Biotechnology
Other subject
07 Sep 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA reacts to the press release issued by Hybrigenics
20103010 Biotechnology
Other subject
30 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
20103010 Biotechnology
Other subject
30 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics annonce les résultats principaux de l'étude de Phase III évaluant son viscosupplément amélioré, le JTA-004, dans l'arthrose du genou
20103010 Biotechnology
Other subject
27 Aug 2021
21:00 CEST
BONE THERAPEUTICS
Bone Therapeutics strengthens its financial structure with the implementation of its financing agreement with the European Investment Bank and the reception of a disbursement offer for the first tranche of €8.0 million
20103010 Biotechnology
Other subject
27 Aug 2021
21:00 CEST
BONE THERAPEUTICS
Bone Therapeutics renforce sa structure financière grâce à la mise en œuvre de son accord de financement avec la Banque Européenne d’Investissement et la réception d'une offre de déboursement concernant la première tranche de 8,0 M€
20103010 Biotechnology
Other subject
06 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 23 August 2021
20103010 Biotechnology
General meeting / Board Meeting
06 Aug 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Convocation à l’Assemblée générale extraordinaire du 23 août 2021
20103010 Biotechnology
General meeting / Board Meeting
27 Jul 2021
19:00 CEST
BONE THERAPEUTICS
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
20103010 Biotechnology
Other subject
27 Jul 2021
19:00 CEST
BONE THERAPEUTICS
Bone Therapeutics et la FSMA s’accordent sur une décision définitive relative à la communication des études cliniques de 2016 et 2017
20103010 Biotechnology
Other subject
19 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics provides update on the progress of clinical studies
20103010 Biotechnology
Other subject
19 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics fait le point sur l’avancement de ses études cliniques
20103010 Biotechnology
Other subject
12 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutic nomme le Dr. Anne Leselbaum, MD, en qualité de Directrice Médicale
20103010 Biotechnology
Corporate life
12 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics appoints Anne Leselbaum, MD as Chief Medical Officer
20103010 Biotechnology
Corporate life
05 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Convocation à l’Assemblée générale extraordinaire du 5 août 2021
20103010 Biotechnology
General meeting / Board Meeting
05 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA: Notice of Extraordinary Shareholders’ Meeting on 5 August 2021
20103010 Biotechnology
General meeting / Board Meeting
01 Jul 2021
07:00 CEST
BONE THERAPEUTICS
La Banque Européenne d’Investissement accorde un prêt de 16 M€ à Bone Therapeutics pour l’accélération du développement clinique et commercial de ses traitements orthopédiques innovants
20103010 Biotechnology
Other subject
01 Jul 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatment
20103010 Biotechnology
Other subject
30 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics publishes results of ALLOB Phase I/IIa study for the treatment of delayed-union fractures in Stem Cell Research & Therapy
20103010 Biotechnology
Other subject
30 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics SA : Publication des résultats de l’étude de phase I/IIa d’ALLOB pour le traitement des fractures à retard de consolidation dans la revue scientifique de référence Stem Cell Research & Therapy
20103010 Biotechnology
Other subject
10 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics announces Annual General Meeting results
20103010 Biotechnology
General meeting / Board Meeting
10 Jun 2021
07:00 CEST
BONE THERAPEUTICS
Bone Therapeutics annonce les résultats de son Assemble Générale Annuelle
20103010 Biotechnology
General meeting / Board Meeting
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Seitennummerierung
«
« First
‹
‹‹
3
4
5
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
your account
section or
create an account
.
Home
Markets
Amsterdam
Cash Products
Stocks
AEX index Stocks
AEX ESG Stocks
Indices
Funds
Bonds
ETFs
Structured products
Derivative products
Index options
Index futures
Stock options
Dividend derivatives
Stock futures
Quote Vendor Codes
Company regulated news
Latest
Archive
Brussels
Cash products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indices
Bonds
ETFs
Structured Products
Derivative products
Index futures
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisbon
Cash Products
Stocks
Euronext regulated
Euronext Access
PSI Stocks
Indices
Bonds
Derivative products
Index futures
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Cash Products
Stocks
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX stocks
OBX ESG Stocks
OSEBX stocks
OSEFX Stocks
Seafood Stocks
Shipping Stocks
Equity indices
Bonds
Oslo Børs
Nordic Alternative Bond Market
Bond indices
ETFs
Funds
Derivatives
Derivative products
Quote Vendor Codes
Company regulated news
Latest
Archive
Financial calendars
Primary insiders
Paris
Cash Products
Stocks
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indices
Bonds
ETFs
Structured products
Derivative products
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
Company regulated news
Latest
Archive
Aktien
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Company regulated news
Latest
Archive
IPOs
All IPOs
Listing sponsors
Euronext Tech Leaders
Family business
Indices
Directory
ESG indices
Indices documents
Indices news
Index consultations
Contact Euronext indices
ETFs
Directory
ESG ETFs
Funds
Directory
ESG Funds
Oslo Mutual Funds
Fixed Income
ESG Bonds
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Structured Products
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Equity Derivatives
Index Futures
Index Options
Stock Options
Stock Futures
Dividend Derivatives
ETF Options
Contracts specifications
Tick Sizes
Wholesale Trading
Quote vendor codes
Rohstoffe
Kurse
Kurse überblick
Weizen Future
Rapssaat Future
Mais Future
European Durum Wheat Futures
Weizen Optionen
Rapssaat Optionen
Mais Optionen
Handelskalender
Lieferung
Wholesale Trading
Commitments of Traders (CoT) report
Spezifikationen
Vendor Codes
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Resources
Statistics & reports
Quality of execution
Trading hours & Holidays
Contract specifications
Quote vendor codes
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Market events
Suspended instruments
Stressed Market Conditions
Breach of Double Cap limits
Exceptional Market Conditions
Miscellaneous short messages
Market status
Members list
Issuers compliance
Where to find